Anna Klose

Anna Klose

Auto-generated profile, based on publicly available information

Anna Klose

Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5, 00790 Helsinki, Finland

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2024 in Nanoscale
Verified
Journal Article
Open access
PDF file
AKAnna Klose
Anna Klose
ZGZahra Gounani
Zahra Gounani
HIHeini Ijäs
Heini Ijäs
TLTatu Lajunen
Tatu Lajunen
Veikko LinkoVeikko Linko
Veikko Linko
TLTimo J Laaksonen
Timo J Laaksonen
Doxorubicin-loaded DNA origami required additional Mg2+ to be stable in cell medium and vitreous at 37 °C. In retinal epithelial cells (ARPE-19), they were well-tolerated, but limited in their uptake.

24 June 2025 in ACS Applied Nano Materials
Verified
Journal Article
Open access
ELEkaterina S. Lisitsyna
Ekaterina S. Lisitsyna
AKAnna Klose
Anna Klose
EVElina Vuorimaa-Laukkanen
Elina Vuorimaa-Laukkanen
HIHeini Ijäs
Heini Ijäs
TLTatu Lajunen
Tatu Lajunen
TLTimo J Laaksonen
Timo J Laaksonen
Owing to doxorubicin’s high DNA binding affinity, doxorubicin-loaded DNA origami nanostructures (DOX-DONs) are promising nanocarriers against cancer. However, understanding the interactions between doxorubicin (DOX) and DNA origami nanostructures (DONs) is important to ensure the quality of DOX-DONs. This interaction is often taken for granted and the influence of DOX loading conditions is poorly characterized. Exploiting the inherent fluorescence of DOX, steady-state and time-resolved fluorescence anisotropy spectroscopy techniques are used for characterizing nondestructively the binding between DOX and DONs, and the purity of the formed complexes. The difference in fluorescence anisotropy between free DOX and DOX-DONs confirms the DOX-DON complex formation. Further, at loading ratios of DOX to DNA base pairs >0.5, homo-Förster resonance energy transfer (homo-FRET) between closely packed DOX molecules is observed. Moreover, time-resolved anisotropy reveals DOX aggregation on DONs at high loading ratios >1. For loading ratios >0.1, spin-filtration to remove excess free DOX is efficient and necessary, though at loading ratios >1 some DOX aggregates remain attached to the DONs. In summary, fluorescence anisotropy analysis provides more detailed information and insight into DOX-DONs compared to the regularly used fluorescence intensity-based characterization methods, and these results can help designing more efficient and safer DNA intercalator-based nanocarriers.

20 June 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
ELEkaterina S. Lisitsyna
Ekaterina S. Lisitsyna
AKAnna Klose
Anna Klose
EVElina Vuorimaa-Laukkanen
Elina Vuorimaa-Laukkanen
HIHeini Ijäs
Heini Ijäs
TLTatu Lajunen
Tatu Lajunen
TLTimo J Laaksonen
Timo J Laaksonen
Owing to doxorubicin’s high DNA binding affinity, doxorubicin-loaded DNA origami nanostructures (DOX-DONs) are promising nanocarriers against cancer. However, understanding the interactions between doxorubicin (DOX) and DNA origami nanostructures (DONs) is important to ensure the quality of DOX-DONs. This interaction is often taken for granted and the influence of DOX loading conditions is poorly characterized. Exploiting the inherent fluorescence of DOX, steady-state and time-resolved fluorescence anisotropy spectroscopy techniques are used for characterizing non-destructively the binding between DOX and DONs, and the purity of formed complexes. The difference in fluorescence anisotropy between free DOX and DOX-DONs confirms the DOX-DON complex formation. Further, at loading ratios of DOX to DNA base pairs > 0.5, homo-Förster resonance energy transfer (homo-FRET) between closely packed DOX molecules is observed. Moreover, time-resolved anisotropy reveals DOX aggregation on DONs at high loading ratios > 1. For loading ratios > 0.1, spin-filtration to remove excess free DOX is efficient and necessary, though at loading ratios > 1 some DOX aggregates remain attached to the DONs. In summary, fluorescence anisotropy analysis provides more detailed information and insight into DOX-DONs compared to regularly used fluorescence intensity-based characterization methods, and these results can help designing more efficient and safer DNA intercalator-based nanocarriers.

25 September 2026 in Small Structures
Verified
Journal Article
Open access
PDF file
AKAnna Klose
Anna Klose
ZGZahra Gounani
Zahra Gounani
Sergei RaikSergei Raik
Sergei Raik
AKArtturi Koivuniemi
Artturi Koivuniemi
SKSonja Korhonen
Sonja Korhonen
TLTimo J Laaksonen
Timo J Laaksonen
DNA origami nanoparticles (DONs) are attractive nanocarriers of controllable size, shape, and addressability that have potential for treating eye diseases by overcoming ocular barriers. However, suboptimal physiological stability and poor cell uptake due to the negative charge may limit their use. Previous reports show that electrostatic complexation of DONs with cationic PEG‐oligolysine block copolymers like PEG5K‐K10 can improve structural integrity and promote cell internalization. Here, we investigated a dual approach of PEG5K‐K10 coatings and PL3‐targeting peptides to improve uptake of 24‐helix bundle (24HB) DONs into Y‐79 retinoblastoma cells. Uptake studies revealed that PEG5K‐K10 was essential for DON uptake in Y‐79 cells, as uptake only occurred upon exceeding a distinct PEG5K‐K10 amount. Longer exposure times or increased polymer amounts improved cell association. However, no beneficial effect of PL3 was observed. While free PEG5K‐K10 reduced cell viability at higher concentrations (IC 50 36.8 µM), coated DONs were well‐tolerated. Furthermore, single particle tracking in ex vivo porcine eyes revealed comparable vitreal mobility for uncoated and coated 24HB, with a slight decrease at higher coating amounts. Our findings highlight that PEG5K‐K10 can enhance ocular cell uptake without limiting nanoparticle diffusivity in the vitreous and support further optimization of DONs for ocular drug delivery.

10 June 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
AKAnna Klose
Anna Klose
ZGZahra Gounani
Zahra Gounani
Sergei RaikSergei Raik
Sergei Raik
AKArtturi Koivuniemi
Artturi Koivuniemi
SKSonja Korhonen
Sonja Korhonen
TLTimo J Laaksonen
Timo J Laaksonen
DNA origami nanoparticles (DONs) are attractive nanocarriers of controllable size, shape and addressability that have potential for treating eye diseases by overcoming ocular barriers. However, suboptimal physiological stability and poor cell uptake due to the negative charge may limit their use. Previous reports show that electrostatic complexation of DONs with cationic PEG-oligolysine block-copolymers like PEG5K-K10 can improve structural integrity and promote cell internalization. Here, we investigated a dual approach of PEG5K-K10 coatings and PL3 targeting peptides to improve uptake of 24-helix bundle (24HB) DONs into Y-79 retinoblastoma cells. Uptake studies revealed that PEG5K-K10 was essential for DON uptake in Y-79 cells, as uptake only occurred upon exceeding a distinct PEG5K-K10 amount. Longer exposure times or increased polymer amounts improved cell association. However, no beneficial effect of PL3 was observed. While free PEG5K-K10 reduced cell viability at higher concentrations (IC 50 36.8 µM), coated DONs were well-tolerated. Furthermore, single particle tracking in ex vivo porcine eyes revealed comparable vitreal mobility for uncoated and coated 24HB, with a slight decrease at higher coating amounts. Our findings highlight that PEG5K-K10 can enhance ocular cell uptake without limiting nanoparticle diffusivity in the vitreous, and support further optimization of DONs for ocular drug delivery.